Wolf James G. 4

4 · ENZO BIOCHEM INC · Filed Feb 13, 2023

Form 4

Period: 2023-02-10

10% Owner

Transactions

Purchase
Common Stock, $0.01 par value
2023-02-10$1.29/sh+5,000$6,450→ 4,095,000 total
Purchase
Common Stock, $0.01 par value
2023-02-13$1.28/sh+5,000$6,425→ 4,100,000 total
Purchase
Common Stock, $0.01 par value
2023-02-13$1.29/sh+5,000$6,450→ 115,000 total(indirect: See Footnote)
Sale
Long Call Option (right to buy)
2023-02-13$0.19/sh−324$62→ 483 total
Exercise: $5.00From: 2022-10-28Exp: 2023-04-21→ Common Stock, $0.01 par value (32,400 underlying)
Sale
Short Put Option (obligation to buy)
2023-02-13$1.01/sh+324$327→ 324 total
Exercise: $2.50From: 2023-02-13Exp: 2023-07-21→ Common Stock, $0.01 par value (32,400 underlying)
Sale
Short Put Option (obligation to buy)
2023-02-13$0.03/sh−750$23→ 0 total
Exercise: $7.50From: 2022-10-28Exp: 2023-04-21→ Common Stock, $0.01 par value (75,000 underlying)
Sale
Short Put Option (obligation to buy)
2023-02-13$1.12/sh+750$840→ 2,163 total
Exercise: $2.50From: 2023-02-13Exp: 2023-04-21→ Common Stock, $0.01 par value (75,000 underlying)

Holdings

Common Stock, $0.01 par value
(indirect: See Footnote)
308,500
Long Call Option (right to buy)
Exercise: $2.50From: 2022-10-28Exp: 2023-04-21→ Common Stock, $0.01 par value (100,000 underlying)
1,000

Footnotes (2)

[F1]The transaction was completed in the name and for the benefit of the Reporting Person's sibling. The Reporting Person maintains a power of attorney granted by the Reporting Person's sibling with respect to these shares, including voting and dispositive power over the shares. The Reporting Person has no pecuniary interest in the shares and disclaims beneficial ownership of the securities held by his sibling. This report will not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.
[F2]The 308,500 shares owned indirectly by the Reporting Person include 116,000 shares held in qualified retirement accounts in the name, and for the benefit, of the Reporting Person, 22,000 shares held in qualified retirement accounts in the name, and for the benefit, of the Reporting Person's spouse and 170,500 shares owned directly by adult children of the Reporting Person.

Documents

1 file